Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 8/31/2023 | 5/31/2022 | 5/31/2021 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 137.8% | -70.1% | 3.7% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 44.9% | 68.8% | 37.8% | 76.8% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -109.6% | -384.6% | -217.4% | -107.5% |
| Net Income | -£0 | £0 | -£0 | -£0 |
| % Margin | -132.5% | 356.3% | -246.5% | -124.3% |
| EPS Diluted | -0.049 | 0.057 | -0.15 | -0.072 |
| % Growth | -186.4% | 137.7% | -109.2% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |